Skip to content

Clinical trials

Phase 1 Inflammation trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Inflammation Phase: Phase 1 Country / region: Germany Clear all

12 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20091
20102
20112
20123
20132
20221
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed11
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novo Nordisk A/S4
AstraZeneca1
InflaRx GmbH1
Innate Pharma1
Janssen Research & Development, LLC1
Novartis Pharmaceuticals1
Pulmatrix Inc.1
Technical University of Munich1
X-pert Med GmbH1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Inflammation12
Arthritis, Rheumatoid6
Autoimmune Diseases1
Blood Coagulation Disorders1
Cardiovascular Diseases1
Death1
Death, Sudden1
Death, Sudden, Cardiac1
Heart Diseases1
Lupus Erythematosus, Systemic1

Trials

Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.